Transfusion-related adverse events in the Platelet Dose study. - Wikidata - wikimedia - TriplyDB

Transfusion-related adverse events in the Platelet Dose study.

Transfusion-related adverse events in the Platelet Dose study.

http://www.wikidata.org/entity/Q27346544

about

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation Transfusion as an Inflammation Hit: Knowns and Unknowns I am the 9%: Making the case for whole-blood platelets.Cryopreserved platelet concentrate transfusions in 43 dogs: a retrospective study (2007-2013).Continued decline in blood collection and transfusion in the United States-2015 Storage time of platelet concentrates and all-cause bacteremia in hematologic patients.Platelet concentrates modulate myeloid dendritic cell immune responses.The platelets' perspective to pathogen reduction technologies.Duration of platelet storage and outcomes of critically ill patients.Repeated exposure rather than the total volume of transfused components may influence the incidence of allergic transfusion reactions.Classification of posttransfusion adverse events using a Web-based algorithm.Prolonged platelet storage associated with increased frequency of transfusion-related adverse events.Agonist-induced platelet reactivity correlates with bleeding in haemato-oncological patients.Clinical utility of a passive immune basophil activation test for the analysis of allergic transfusion reactions.Red blood cell non-ABO-identical transfusions are harmful: really?Mitochondrial damage-associated molecular patterns as potential proinflammatory mediators in post-platelet transfusion adverse effects.Factors related to allergic transfusion reactions and febrile non-haemolytic transfusion reactions in children.Platelet proteins cause basophil histamine release through an immunoglobulin-dependent mechanism.Platelet storage duration and its clinical and transfusion outcomes: a systematic review

P2860

Q24186359-32E2B983-DF03-4448-AE99-5D4B247F7D28 Q24187751-DC1D1B41-694C-4115-987A-8F6AADE06E49 Q28074933-ABE767BE-99C4-4F61-82A9-CB061BF69669 Q33432190-B70AD8BF-D3FA-44C8-AEE8-CBFC56AA395E Q33433620-B11B480D-2BB1-4925-A306-75404F322A76 Q38738078-341AC977-375A-49C0-8546-F94EC9897B4A Q40144289-C5043E57-9C09-459D-9ADA-C3569A3DAFB0 Q40201595-2A6FA335-4834-417A-A454-41664ED12E08 Q40273685-84E4B1B1-31DB-4BC5-A9DA-3121F8C8DADB Q40290880-6FFF05C2-219D-409D-9516-8496EAA8AAF7 Q40815665-9C0299FB-4546-463F-8B4E-84502D66898B Q47973260-031062A4-48B0-4FF5-84FE-5E7EBE927BA7 Q48112813-63FF6768-10C6-4241-8C12-F3D781B84008 Q48272685-D9442593-3071-416B-B6FA-0A812A475223 Q50203875-4A7FD4EA-B587-42B7-B224-F3DE46BB62A1 Q50249787-4C068C0E-B95D-4534-A99C-E35FDA75F3F6 Q50252158-2BF69FF5-46CC-4E9B-BF59-4F327DCB45F4 Q50266154-C552B5A3-7F7C-403F-8FCC-53FC3B54010E Q51021097-3E95BB24-D5AA-471C-818C-C73CAC6E3DC1 Q58800181-190A9EC6-99A0-4ED0-8F01-AE2F1B8943F7

P2860

Transfusion-related adverse events in the Platelet Dose study.

http://www.wikidata.org/entity/Q27346544

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Transfusion-related adverse events in the Platelet Dose study

@nl

Transfusion-related adverse events in the Platelet Dose study.

@ast

Transfusion-related adverse events in the Platelet Dose study.

@en

type

label

Transfusion-related adverse events in the Platelet Dose study

@nl

Transfusion-related adverse events in the Platelet Dose study.

@ast

Transfusion-related adverse events in the Platelet Dose study.

@en

prefLabel

Transfusion-related adverse events in the Platelet Dose study

@nl

Transfusion-related adverse events in the Platelet Dose study.

@ast

Transfusion-related adverse events in the Platelet Dose study.

@en

P1433

Q27346544-8C680249-9EE4-4F79-A297-08BAAEE59B9D

P1476

Q27346544-D3C8E651-8446-4A25-A029-D1F92EBBD71B

P2093

Q27346544-0B598DF9-C5F6-4C24-AD7C-383D9B09402E

Q27346544-0EED17AB-B87D-4238-A2F7-57F50DC7EE65

Q27346544-0F4A200A-7CD4-4BD2-84B7-B20358C3D368

Q27346544-40E96F76-644E-4060-B0EF-EFB336EFE006

Q27346544-7A44CFE4-2A44-4D14-9E92-81634E13DDE8

Q27346544-8CB537D5-821A-457A-A424-DA261BE69F44

Q27346544-A600C19F-18EA-40FE-B70F-4534FE72C88A

P2860

Q27346544-0AF02CA9-DDB2-45E2-BC83-6188A450CF1C

Q27346544-17601DB2-C804-439C-99FA-235C3B8B5E38

Q27346544-2DD1CEC9-79F0-45C4-B1BA-81EF54F70872

Q27346544-4F39A2CE-73E3-457E-8B12-94A7ACF79A6C

Q27346544-5B2988A8-9A42-4EC5-BFA0-7AC07F1A2A55

Q27346544-5DF513B9-E3D8-4DCF-A017-FECB8A3219D1

Q27346544-70197CB9-568E-476E-99C5-F2CAE8A38142

Q27346544-86FB992B-127F-4243-829E-FD000051484A

Q27346544-9687FADB-9394-4C79-A52F-8181FBD24B57

Q27346544-DD193BBA-717F-4A86-A6C9-D4D3B0D53BA8

P304

Q27346544-B9A960A4-EF57-4444-AA83-2E88D94914FE

P31

Q27346544-012E423F-D854-4AEC-84ED-936F2D286049

P356

Q27346544-6C8D189E-A1AE-4051-A802-1D13DE63E36C

P407

Q27346544-CC8E6195-76D3-4596-82F8-9B6378AF1FA0

P433

Q27346544-59987E02-ECAE-4560-9502-AC64D0056865

P478

Q27346544-0113FC28-67CF-45AC-9899-073A6E3CAC4A

P577

Q27346544-068B31E1-9978-4193-981B-90946C95A7B6

P5875

Q27346544-C3520A54-C34D-4872-B2DC-D0485D289463

P698

Q27346544-CD612B55-ACA4-474D-B37F-0293F52CE609

P932

Q27346544-E46BBB01-91C9-4A69-9847-ABAD300C0382

P356

P1433

P1476

Transfusion-related adverse events in the Platelet Dose study.

@en

P2093

Darrell J Triulzi

http://www.w3.org/2001/XMLSchema#string

Paul Ness

http://www.w3.org/2001/XMLSchema#string

Richard M Kaufman

http://www.w3.org/2001/XMLSchema#string

Ronald G Strauss

http://www.w3.org/2001/XMLSchema#string

Sherrill J Slichter

http://www.w3.org/2001/XMLSchema#string

Susan F Assmann

http://www.w3.org/2001/XMLSchema#string

Suzanne Granger

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions

Reporting results of cancer treatment

Dose of prophylactic platelet transfusions and prevention of hemorrhage

The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia.

The role of the plasma from platelet concentrates in transfusion reactions.

Defining risk factors and presentations of allergic reactions to platelet transfusion

Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes.

Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?

Transfusion premedications: a growing practice not based on evidence.

Desensitization in allergic transfusion reactions: evidence from the Trial to Reduce Alloimmunization to Platelets.

P304

144-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRF.12791

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264289553

http://www.w3.org/2001/XMLSchema#string

P698

25065959

http://www.w3.org/2001/XMLSchema#string

P932

4293226

http://www.w3.org/2001/XMLSchema#string